{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T23:16:26Z","timestamp":1774048586547,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001361","name":"Faculty of Science, National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.phrs.2020.104687","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T20:27:27Z","timestamp":1581366447000},"page":"104687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Venom natriuretic peptides guide the design of heart failure therapeutics"],"prefix":"10.1016","volume":"155","author":[{"given":"Sindhuja","family":"Sridharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Manjunatha","family":"Kini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2020.104687_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global Public Health Burden of Heart Failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.phrs.2020.104687_bib0010","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2020.104687_bib0015","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(05)66621-4","article-title":"Heart failure","volume":"365","author":"McMurray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2020.104687_bib0020","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1056\/NEJMp1410203","article-title":"PARADIGM-HF--the experts\u2019 discussion","volume":"371","author":"Jessup","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phrs.2020.104687_bib0025","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"European heart journal"},{"key":"10.1016\/j.phrs.2020.104687_bib0030","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2020.104687_bib0035","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","article-title":"Heart failure with preserved ejection fraction: from mechanisms to therapies","volume":"39","author":"Lam","year":"2018","journal-title":"European heart journal"},{"key":"10.1016\/j.phrs.2020.104687_bib0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cardfail.2013.01.007","article-title":"The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and design","volume":"19","author":"Santhanakrishnan","year":"2013","journal-title":"Journal of cardiac failure"},{"key":"10.1016\/j.phrs.2020.104687_bib0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","article-title":"Acute Heart Failure: Definition, Classification and Epidemiology","volume":"14","author":"Kurmani","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.phrs.2020.104687_bib0050","doi-asserted-by":"crossref","first-page":"32G","DOI":"10.1016\/j.amjcard.2005.07.019","article-title":"Evaluation and monitoring of patients with acute heart failure syndromes","volume":"96","author":"Nohria","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.phrs.2020.104687_bib0055","first-page":"510","article-title":"Acute decompensated heart failure: contemporary medical management","volume":"36","author":"Joseph","year":"2009","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.phrs.2020.104687_bib0060","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0735-1097(03)00309-7","article-title":"Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure","volume":"41","author":"Nohria","year":"2003","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.phrs.2020.104687_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"28","author":"de Bold","year":"1981","journal-title":"Life sciences"},{"key":"10.1016\/j.phrs.2020.104687_bib0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/313397a0","article-title":"Structural identification of beta- and gamma-human atrial natriuretic polypeptides","volume":"313","author":"Kangawa","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2020.104687_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-291X(84)91077-5","article-title":"Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP)","volume":"118","author":"Kangawa","year":"1984","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.phrs.2020.104687_bib0080","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","article-title":"C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain","volume":"168","author":"Sudoh","year":"1990","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.phrs.2020.104687_bib0085","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ajh\/4.11.909","article-title":"Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes","volume":"4","author":"Nakamura","year":"1991","journal-title":"American journal of hypertension"},{"key":"10.1016\/j.phrs.2020.104687_bib0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0006-291X(85)91406-8","article-title":"Atrial natriuretic polypeptides (ANP): rat atria store high molecular weight precursor but secrete processed peptides of 25-35 amino acids","volume":"129","author":"Vuolteenaho","year":"1985","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.phrs.2020.104687_bib0095","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.M301223200","article-title":"Furin-mediated processing of Pro-C-type natriuretic peptide","volume":"278","author":"Wu","year":"2003","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.phrs.2020.104687_bib0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1373\/clinchem.2011.165704","article-title":"Use of natriuretic peptides to guide and monitor heart failure therapy","volume":"58","author":"Richards","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.phrs.2020.104687_bib0105","doi-asserted-by":"crossref","first-page":"12104","DOI":"10.1016\/S0021-9258(18)45322-7","article-title":"Two distinct forms of receptors for atrial natriuretic factor in bovine adrenocortical cells. Purification, ligand binding, and peptide mapping","volume":"262","author":"Takayanagi","year":"1987","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.phrs.2020.104687_bib0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.130.1.1309330","article-title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide","volume":"130","author":"Suga","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2020.104687_bib0115","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/j.1460-2075.1989.tb03518.x","article-title":"Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction","volume":"8","author":"Lowe","year":"1989","journal-title":"The EMBO journal"},{"key":"10.1016\/j.phrs.2020.104687_bib0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocrine reviews"},{"key":"10.1016\/j.phrs.2020.104687_bib0125","first-page":"R109","article-title":"Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP","volume":"271","author":"John","year":"1996","journal-title":"The American journal of physiology"},{"key":"10.1016\/j.phrs.2020.104687_bib0130","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phrs.2020.104687_bib0135","doi-asserted-by":"crossref","first-page":"23060","DOI":"10.1016\/S0021-9258(18)54463-X","article-title":"Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera","volume":"266","author":"Bennett","year":"1991","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.phrs.2020.104687_bib0140","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phrs.2020.104687_bib0145","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.peptides.2004.09.023","article-title":"Natriuretic peptide receptor-C signaling and regulation","volume":"26","author":"Anand-Srivastava","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.phrs.2020.104687_bib0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj2430183","article-title":"The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11","volume":"243","author":"Stephenson","year":"1987","journal-title":"The Biochemical journal"},{"key":"10.1016\/j.phrs.2020.104687_bib0155","first-page":"R373","article-title":"Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep","volume":"271","author":"Charles","year":"1996","journal-title":"The American journal of physiology"},{"key":"10.1016\/j.phrs.2020.104687_bib0160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/HYPERTENSIONAHA.109.135608","article-title":"Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function","volume":"54","author":"Palmer","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2020.104687_bib0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/hrt.69.5.414","article-title":"Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease","volume":"69","author":"Richards","year":"1993","journal-title":"British heart journal"},{"key":"10.1016\/j.phrs.2020.104687_bib0170","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/0024-3205(86)90137-2","article-title":"Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man","volume":"38","author":"Yandle","year":"1986","journal-title":"Life sciences"},{"key":"10.1016\/j.phrs.2020.104687_bib0175","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1016\/S0021-9258(19)49658-0","article-title":"A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps)","volume":"267","author":"Schweitz","year":"1992","journal-title":"The Journal of biological chemistry"},{"key":"10.1016\/j.phrs.2020.104687_bib0180","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/sj.bjp.0706924","article-title":"Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation","volume":"149","author":"Singh","year":"2006","journal-title":"British journal of pharmacology"},{"key":"10.1016\/j.phrs.2020.104687_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2007.04.079","article-title":"Dendroaspis natriuretic peptide binds to the natriuretic peptide clearance receptor","volume":"358","author":"Johns","year":"2007","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.phrs.2020.104687_bib0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yjmcc.2011.03.013","article-title":"Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation","volume":"51","author":"Dickey","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.phrs.2020.104687_bib0195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2008.02.077","article-title":"Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP","volume":"52","author":"Lisy","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.phrs.2020.104687_bib0200","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1002\/pmic.200402024","article-title":"Snake venomics: comparative analysis of the venom proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina","volume":"5","author":"Bazaa","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.phrs.2020.104687_bib0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0014-5793(96)00774-0","article-title":"Novel anti-platelet aggregation polypeptides from Vipera lebetina venom: isolation and characterization","volume":"392","author":"Barbouche","year":"1996","journal-title":"FEBS letters"},{"key":"10.1016\/j.phrs.2020.104687_bib0210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0014-5793(03)01455-8","article-title":"Functional and structural characterization of a novel member of the natriuretic family of peptides from the venom of Pseudocerastes persicus","volume":"557","author":"Amininasab","year":"2004","journal-title":"FEBS letters"},{"key":"10.1016\/j.phrs.2020.104687_bib0215","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bbrc.2004.11.171","article-title":"Novel natriuretic peptides from the venom of the inland taipan (Oxyuranus microlepidotus): isolation, chemical and biological characterisation","volume":"327","author":"Fry","year":"2005","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.phrs.2020.104687_bib0220","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.biochi.2006.06.014","article-title":"Cloning and characterisation of natriuretic peptides from the venom glands of Australian elapids","volume":"88","author":"St Pierre","year":"2006","journal-title":"Biochimie"},{"key":"10.1016\/j.phrs.2020.104687_bib0225","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1002\/anie.201411914","article-title":"A defined alpha-helix in the bifunctional O-glycosylated natriuretic peptide TcNPa from the venom of Tropidechis carinatus","volume":"54","author":"Reeks","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.phrs.2020.104687_bib0230","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2199-11-24","article-title":"Transcriptomic analysis of the venom gland of the red-headed krait (Bungarus flaviceps) using expressed sequence tags","volume":"11","author":"Siang","year":"2010","journal-title":"Bmc Mol Biol"},{"key":"10.1016\/j.phrs.2020.104687_bib0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/BJ20150281","article-title":"Tail wags the dog: activity of krait natriuretic peptide is determined by its C-terminal tail in a natriuretic peptide receptor-independent manner","volume":"469","author":"Sridharan","year":"2015","journal-title":"The Biochemical journal"},{"key":"10.1016\/j.phrs.2020.104687_bib0240","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.phrs.2020.104687_bib0245","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1152\/physrev.1990.70.3.665","article-title":"Diverse biological actions of atrial natriuretic peptide","volume":"70","author":"Brenner","year":"1990","journal-title":"Physiological reviews"},{"key":"10.1016\/j.phrs.2020.104687_bib0250","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/14728222.10.2.239","article-title":"Natriuretic peptides as therapeutic targets","volume":"10","author":"Mukaddam-Daher","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.phrs.2020.104687_bib0255","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure (vol 343, pg 246, 2000)","volume":"343","author":"Colucci","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.phrs.2020.104687_bib0260","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9149(90)90087-H","article-title":"Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure","volume":"65","author":"Fifer","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.phrs.2020.104687_bib0265","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00005344-199906000-00016","article-title":"Long-term administration of atrial natriuretic peptide in patients with acute heart failure","volume":"33","author":"Kitashiro","year":"1999","journal-title":"Journal of cardiovascular pharmacology"},{"key":"10.1016\/j.phrs.2020.104687_bib0270","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.MAT.0000065370.44623.6E","article-title":"Synthetic human alpha-atrial natriuretic peptide infusion in management after open heart operations","volume":"49","author":"Hayashi","year":"2003","journal-title":"ASAIO J"},{"key":"10.1016\/j.phrs.2020.104687_bib0275","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajem.2004.11.002","article-title":"Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure","volume":"23","author":"Peacock","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.phrs.2020.104687_bib0280","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phrs.2020.104687_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-5299.2004.03405.x","article-title":") Beyond the four quadrants: the critical and emerging role of impedance cardiography in heart failure","volume":"10","author":"Strobeck","year":"2004","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.phrs.2020.104687_bib0290","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1126\/science.270.5242.1657","article-title":"Minimization of a polypeptide hormone","volume":"270","author":"Li","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.phrs.2020.104687_bib0295","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1172\/JCI118881","article-title":"Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats","volume":"98","author":"Jin","year":"1996","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.phrs.2020.104687_bib0300","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.08.001","article-title":"Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications","volume":"75","author":"Ichiki","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.phrs.2020.104687_bib0305","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/0091270009336233","article-title":"Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects","volume":"49","author":"Lee","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.phrs.2020.104687_bib0310","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.0811851106","article-title":"Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide","volume":"106","author":"Pan","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.phrs.2020.104687_bib0315","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.110.159210","article-title":"A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension","volume":"56","author":"McKie","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2020.104687_bib0320","first-page":"R449","article-title":"Renal response of anesthetized rats to low-dose infusion of atrial natriuretic peptide","volume":"255","author":"Soejima","year":"1988","journal-title":"The American journal of physiology"},{"key":"10.1016\/j.phrs.2020.104687_bib0325","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BCJ20170690","article-title":"Decoding the molecular switches of natriuretic peptides which differentiate its vascular and renal functions","volume":"475","author":"Sridharan","year":"2018","journal-title":"The Biochemical journal"},{"key":"10.1016\/j.phrs.2020.104687_bib0330","series-title":"Structure-function relationships and action mechanism of krait natriuretic peptide","author":"Sridharan","year":"2014"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819321371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819321371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:07:01Z","timestamp":1760911621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819321371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":66,"alternative-id":["S1043661819321371"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104687","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venom natriuretic peptides guide the design of heart failure therapeutics","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104687"}}